Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 3, 2003

View Archived Issues

Effective control of plaque psoriasis achieved with continuous efalizumab

Antitumor effects of irofulven in advanced cancer

Clinical trials confirm the good safety profile of anecorvate acetate

Radiosensitizing effects of GW-572016 and use in combination chemotherapy

Preclinical and clinical antitumor efficacy and clinical safety of Bay-43-9006

R&D highlights from the 3rd Annual Biotech in Europe Investor Forum: Rejuvenon

Beneficial effects of SKI-606 in rat models of stroke

Antiproliferative and cytotoxic effects of aplidine assessed in human cancer cell lines

In vitro efficacy of 2-methoxyestradiol in prostate and pancreatic cancer

New CRF1 antagonists with utility in anxiety and depression

BMS researchers describe new p38 kinase inhibitors and their therapeutic use

New anxiolytic agents prepared and tested by Egis researchers

Roche claims novel alpha1A-adrenoceptor agonists for urinary incontinence and other uses

Novel IBAT inhibitors identified at AstraZeneca

New antibacterial agents described by the former British Biotech (now Vernalis)

Fast track designation for TheraCLEC

Melanotan reduces sunburn injury by increasing melanin density in clinical trial

Celltech to regain rights to CDP-870 from Pfizer

Ganymed acquires ImmuGenics, inlicenses TCR intellectual property

FDA accepts Avastin BLA for priority review

First approval for Erbitux granted by Swiss authorities

IsoTis OrthoBiologics establishes EpiSource subsidiary for wound care portfolio

Neurogen and Merck & Co. target vanilloid receptor through new alliance

Keppra reduces seizures in epileptic patients with brain tumors

P2Y1 receptor antagonists with enhanced potency designed by U.S.-Korean group

R&D highlights from the 3rd Annual Biotech in Europe Investor Forum: Xantos Biomedicine

Antiparkinsonian and antidyskinesia effects of GR-127935, a 5-HT1B/1D receptor antagonist

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...